Background on Roundup and Cancer Allegations
Common claims focus on non-Hodgkin lymphoma and other cancers developing after prolonged exposure. While the EPA maintains glyphosate is not likely carcinogenic when used as directed, numerous jury verdicts have sided with plaintiffs, awarding billions in damages.
Key Roundup Lawsuit Updates in 2026
The litigation shows no signs of slowing down in 2026. Here’s what’s happening now:
- Ongoing Settlements and Reserves — Bayer has paid nearly $11 billion to settle over 100,000 claims to date. However, thousands remain unresolved. In mid-2025, Bayer added $1.37 billion to its litigation reserves, signaling continued payouts. As of early 2026, estimates suggest around 61,000 active cases, with some sources reporting over 4,500 in federal multidistrict litigation (MDL) in California.
- Recent Trial Outcomes — Bellwether trials in 2025 and early 2026 have produced mixed results, but several large plaintiff verdicts (some in the hundreds of millions) continue to pressure Bayer. For example, appellate courts have upheld significant awards, including a $611 million verdict in Missouri. These outcomes keep settlement discussions active.
- Supreme Court Petition — In a major development, Bayer petitioned the U.S. Supreme Court in late 2025 to rule on whether federal pesticide labeling laws preempt state failure-to-warn claims. The Trump administration’s Solicitor General supported Bayer’s position in December 2025, arguing for federal preemption. The Court may decide soon whether to hear the case (Monsanto v. Durnell), which could dramatically reduce future lawsuits if decided in Bayer’s favor.
- Other Developments — Efforts to add pesticide immunity provisions to federal funding bills stalled in early 2026. Meanwhile, new filings continue, and Bayer faces jurisdictional challenges in states like New Jersey.
These updates highlight that while many cases have settled, the door remains open for new and pending claims.
What This Means for Potential Victims
If you’ve been diagnosed with non-Hodgkin lymphoma or another related cancer after regular Roundup use, timing is critical due to statutes of limitations (varying by state, often 2–4 years from diagnosis or discovery).Key factors courts consider:
- Proof of exposure (e.g., product use records, work history)
- Medical diagnosis linking to glyphosate
- No adequate warning on labels
Many victims qualify even without “heavy” use—home gardeners and occasional users have succeeded in claims.
Next Steps If You May Have a Claim
- Document Your Exposure — Gather records of Roundup purchases, usage dates, and duration.
- Review Your Medical History — Note diagnosis date and any links to lymphoma or related conditions.
- Consult Professionals — Mass tort claims are often handled on a contingency basis—no upfront fees.
The litigation’s momentum in 2026 suggests settlements or resolutions could continue, but acting promptly preserves your rights.
Concerned about Roundup exposure or a non-Hodgkin lymphoma diagnosis? Submit your confidential information today for a free, no-obligation review from our team. We’re here to help answer questions and guide you through the process.
